by Stephanie Wood Miller | Apr 30, 2024 | Science, Weekly Cannabis News, Weekly News
According to Associated Press this morning the FDA will move to reclassify marijuana from a Schedule I to a Schedule III drug. Schedule I drugs have a high potential for abuse and no accepted medical use, while Schedule III drugs have a lower potential for abuse and...by Vita Maziveyi | Apr 29, 2024 | Science, Weekly News
Why We Think It’s Important: This article is important as it provides valuable insights into the acute neurocognitive effects of CannEpil, a medicinal cannabis oil, shedding light on its potential therapeutic benefits and safety profile in treating various medical...by Vita Maziveyi | Apr 15, 2024 | Science, Weekly News
Why we think it’s important This study is important because it shows that people with cannabis use disorder have a slightly higher risk of complications and even death during major surgeries compared to those without the disorder. The findings suggest that healthcare...by Vita Maziveyi | Apr 1, 2024 | Science, Weekly News
Why we Think It’s Important: This article highlights the increasing prevalence of cannabis use and its potential impact on cardiovascular health, as revealed by a recent study utilizing data from the Behavioral Risk Factor Surveillance Survey (BRFSS). ...by Vita Maziveyi | Mar 11, 2024 | Science, Weekly Cannabis News
Why we think it’s important: This article is crucial as it sheds light on the increasingly common yet often overlooked risk of cannabis-induced psychosis, exemplified by the alarming case of Bryn Spejcher. By presenting scientific evidence and real-life incidents,...by Vita Maziveyi | Feb 5, 2024 | Communications, Science, Weekly News
Why we think it’s important This study is important because it helps us understand what happened to hospitalizations when Canada made nonmedical cannabis legal. It shows that while there was initially a decrease in hospitalizations right after the law changed, later...